ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 407335 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 407335; 2) Community: the network communities that were significantly associated with the response to NSC 407335; 3) Molecule: the relationships between components within communities and NSC 407335; 4) MDR: the compounds that were significantly associated with the NSC 407335.

NSC Compound Enrichment Correlation
NSC 744076 Null 0.0438391811600412 -0.048503258
NSC 86373 Quinolinium, 4-[2-(8-hydroxy-5-methyl-7-quinolyl)vinyl]-1-methyl- iodide 0.0438391811600412 0.30589676
NSC 610458 Camptothecin Derivative 0.045446901295916 0.60549994
NSC 610459 Camptothecin Derivative 0.045446901295916 0.60647032
NSC 634471 Null 0.045446901295916 -0.14713526
NSC 639174 Camptothecin Derivative 0.045446901295916 0.61866879
NSC 639734 Null 0.045446901295916 -0.011118141
NSC 639978 Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)phenyl] ethylidene]-5-[(1-piperidinyl)methyl]-, hydrochloride 0.045446901295916 -0.018022977
NSC 644960 Null 0.045446901295916 0.65394629
NSC 651081 1H-Pyrrolo[1,2-a]benzimidazole-5,8-dione, 6-(acetylamino)- 2,3-dihydro-3-hydroxy-7-methyl- 0.045446901295916 -0.037054273
Total:40  Current:30    [First] [Prev] [Next] [Last]